Edgewise Therapeutics Inc

NASDAQ:EWTX   2:42:00 PM EDT
16.93
+1.04 (+6.54%)
Products

Edgewise Receives U.S. FDA Fast Track Designation For Edg-5506 For The Treatment Of Individuals With Becker Muscular Dystrophy (Bmd)

Published: 08/16/2021 13:16 GMT
Edgewise Therapeutics Inc (EWTX) - Edgewise Receives U.S. FDA Fast Track Designation for Edg-5506 for the Treatment of Individuals With Becker Muscular Dystrophy (bmd).